Beta Bionics (NASDAQ: BBNX) has claimed an FDA clearance for its first patch pump insulin delivery system, amid plans to roll out an updated diabetes dosing algorithm and the launch of a new CGM partnership with Senseonics.
People with atrial fibrillation have signs of the condition in their retinas that can be detected as early as four years before diagnosis, according to a new study led by University College London (UCL) and Moorfields researchers.
A research team led by UCF College of Medicine assistant professor Hung Nguyen is examining an understudied molecule within T cells as a pathway to treatments for cancers, infections and autoimmune disorders.
Atrial fibrillation is the most common cardiac arrhythmia and increases the risk of conditions such as stroke and heart failure. An established treatment is catheter ablation, in which physicians use thin catheters to create small scars in heart tissue to block the electrical signals that cause the arrhythmia. Despite treatment, many patients with the more difficult-to-treat form, persistent atrial fibrillation, experience recurrence.
When it comes to priorities in life, oxygen tops the list. Humans can go weeks without food and days without water. Take away the ability to breathe, however, and the clock starts ticking within minutes as the brain begins shutting down. But the life-giving gas does even more heavy lifting than you might think.
An experimental drug has been shown to improve symptoms, exercise capacity and heart failure status in patients with an inherited heart disease, according to a pair of newly published studies.
Scholar Rock’s spinal muscular atrophy drug, now to be called Isembyld, was originally rejected in September 2025, when the FDA cited compliance problems at a third-party manufacturer.
Scientists have long believed that large stretches of our genetic material, known as long noncoding RNAs (lncRNAs), help regulate genes but do not produce proteins. A new study by Stav Zok and Professor Michal Linial from the Hebrew University of Jerusalem suggests that this picture is incomplete.
Researchers from the National University of Singapore (NUS) have demonstrated an innovative approach for targeted breast cancer therapy using pulsed electromagnetic fields (PEMFs). The NUS team successfully reprogrammed tumor-associated macrophages (TAMs), a corrupted class of immune cells that typically promote cancer growth, into an active anti-tumor state that attacks and destroys cancer cells.
A research team led by Professor Zhou Xuyu from the Institute of Microbiology of the Chinese Academy of Sciences (CAS), in collaboration with researchers from Beijing Ditan Hospital and Capital Medical University, has identified ANKRD11 as a key regulator that reduces the activity of CD8+ T cells during chronic hepatitis B virus (HBV) infection and cancer. The researchers found that ANKRD11 suppresses the AP-1 signaling pathway, which usually helps CD8+ T cells mount effective responses against infections and tumors.